Under-Utilisation of -Blockers After Acute Myocardial Infarction: Pharmacoeconomic Implications

By Bradford W.D.  

PharmacoEconomics, Vol. 15, Iss. 3, 1999-03 ,pp. : 257-268

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers: Subanalysis of the EPHESUS

By Zhang Zefeng   Mahoney Elizabeth M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 55-63

Adis International

Access to resources Recommend Favorite

Long-Term Treatment with Angiotensin-Converting Enzyme Inhibitors, Beta-Blockers or a Combination of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Low-Risk Patients after Acute Myocardial Infarction: The ABC Study

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 20-25

Karger

Access to resources Recommend Favorite

Discontinuation of β-Blockers and the Risk of Myocardial Infarction in the Elderly

By Teichert Martina   de Smet Peter A.G.M.   Hofman Albert   Witteman Jacqueline C.M.   Stricker Bruno H.Ch.  

Drug Safety, Vol. 30, Iss. 6, 2007-01 ,pp. : 541-549

Adis International

Access to resources Recommend Favorite

Angiotensin receptor blockers in acute myocardial infarction

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 427-430

Informa Healthcare

Access to resources Recommend Favorite